Sino Medical Sciences Technology Inc.
Shanghai Stock ExchangeTotal Valuation
Sino Medical Sciences Technology Inc. carries a market capitalization of 7.81B, placing it among publicly traded companies globally. Its enterprise value stands at 8.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.81B |
| Enterprise Value | 8.13B |
Share Statistics
Sino Medical Sciences Technology Inc. currently has 417.95M shares outstanding.
| Shares Outstanding | 417.95M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Sino Medical Sciences Technology Inc. trades at a trailing price-to-earnings ratio of 134.84. The price-to-sales ratio is 18.81, and the price-to-book ratio stands at 33.32.
| PE Ratio | 134.84 |
| PS Ratio | 18.81 |
| PB Ratio | 33.32 |
| P/TBV Ratio | 19.02 |
| P/FCF Ratio | 247.98 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Sino Medical Sciences Technology Inc. trades at an EV/EBITDA multiple of 87.96 and an EV/FCF ratio of 225.53. The EV/Sales ratio of 18.44 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 87.96 provides insight into valuation relative to core operating earnings.
| EV / Sales | 18.44 |
| EV / EBITDA | 87.96 |
| EV / EBIT | 87.96 |
| EV / FCF | 225.53 |
Financial Position
Sino Medical Sciences Technology Inc. maintains a current ratio of 2.54, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.17, indicating elevated leverage, while an interest coverage ratio of 27.17 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.54 |
| Quick Ratio | 1.86 |
| Debt / Equity | 13.17 |
| Debt / EBITDA | 1.52 |
| Interest Coverage | 27.17 |
Financial Efficiency
Sino Medical Sciences Technology Inc. posts a return on equity of 28.47 and a return on invested capital of 6.18.
| Return on Equity (ROE) | 28.47 |
| Return on Assets (ROA) | 4.71 |
| Return on Invested Capital (ROIC) | 6.18 |
| Return on Capital Employed (ROCE) | 14.46 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.50 |
Taxes
Over the trailing twelve months, Sino Medical Sciences Technology Inc. has paid 19.70M in income taxes, reflecting an effective tax rate of 23.46.
| Income Tax | 19.70M |
| Effective Tax Rate | 23.46 |
Stock Price Statistics
Sino Medical Sciences Technology Inc.'s stock has gained approximately 71.15385% over the past 52 weeks. The 50-day moving average sits at 20.28, while the 200-day moving average is 21.65.
| Beta (5Y) | N/A |
| 52-Week Price Change | 71.15385% |
| 50-Day Moving Average | 20.28 |
| 200-Day Moving Average | 21.65 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Sino Medical Sciences Technology Inc. generated 440.92M in revenue and converted that into 61.50M in net income, yielding earnings per share of 0.16. EBITDA reached 92.42M, while operating income came in at 92.42M.
| Revenue | 440.92M |
| Gross Profit | 299.79M |
| Operating Income | 92.42M |
| Pretax Income | 83.98M |
| Net Income | 61.50M |
| EBITDA | 92.42M |
| EBIT | 92.42M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
Sino Medical Sciences Technology Inc. holds 375.98M in cash and equivalents against 140.20M in total debt, resulting in a net debt position of -261.47M. Total book value stands at 248.89M, with working capital of 311.50M providing operational flexibility.
| Cash & Cash Equivalents | 375.98M |
| Total Debt | 140.20M |
| Net Debt | -261.47M |
| Equity (Book Value) | 248.89M |
| Book Value Per Share | 0.61 |
| Working Capital | 311.50M |
Cash Flow
After subtracting -33.44M in capital expenditures, free cash flow totaled -33.44M - equivalent to -0.08 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -33.44M |
| Free Cash Flow | -33.44M |
| FCF Per Share | -0.08 |
Margins
Sino Medical Sciences Technology Inc. operates with a gross margin of 67.99, reflecting its pricing power and cost economics. The operating margin of 20.96 and net profit margin of 13.95 provide insight into operational efficiency.
| Gross Margin | 67.99 |
| Operating Margin | 20.96 |
| Pretax Margin | 19.05 |
| Profit Margin | 13.95 |
| EBITDA Margin | 20.96 |
Dividends & Yields
The company's payout ratio of 4.23 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | 4.23 |
| Shareholder Yield | 0.55 |
| FCF Yield | 0.40 |
Scores
Sino Medical Sciences Technology Inc. posts an Altman Z-Score of 20.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 20.15 |